Multiple endocrine neoplasia type 2 prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
* Ionized calcium level yearly for MEN 2A | * Ionized [[calcium]] level yearly for MEN 2A | ||
* Parathyroid hormone level yearly for MEN 2A | * [[Parathyroid hormone]] level yearly for MEN 2A | ||
* | * [[Catacholamine]]s, [[epinephrine]] and [[norepinephrine]] yearly for MEN 2A and MEN 2B | ||
* Magnetic resonance imaging and computerized tomography for pheochromocytoma every 2-4 years | * [[Magnetic resonance imaging]] and [[computerized tomography]] for [[pheochromocytoma]] every 2-4 years | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:25, 28 September 2015
|
Multiple endocrine neoplasia type 2 Microchapters |
|
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Multiple endocrine neoplasia type 2 prevention On the Web |
|
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 prevention |
|
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
|
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Secondary Prevention
- Ionized calcium level yearly for MEN 2A
- Parathyroid hormone level yearly for MEN 2A
- Catacholamines, epinephrine and norepinephrine yearly for MEN 2A and MEN 2B
- Magnetic resonance imaging and computerized tomography for pheochromocytoma every 2-4 years